Evaluation of Three SS-OCT and One PCI Optical Biometers in Eyes With Dense Cataract
BIO-CAT-DENSA
1 other identifier
observational
51
1 country
1
Brief Summary
To describe and compare the acquisition rate between different biometers in eyes with advanced cataracts
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2022
CompletedStudy Start
First participant enrolled
February 10, 2022
CompletedFirst Posted
Study publicly available on registry
February 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2022
CompletedSeptember 6, 2023
September 1, 2023
9 months
February 3, 2022
September 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To describe and compare the acquisition rate between different biometers in eyes To describe and compare the acquisition success rate between different biometers in eyes with advanced cataracts
Acquision succes rate is indicated by a percentage, from 0% to 100%. The biometer can obtain (success) or not (failure) the measurement. This value will be indicated for each biometer.
6 months
Secondary Outcomes (1)
To describe the correlation of success rate and Dysfunctional Lens Index (DLI, iTrace)
6 months
Interventions
Biometry using swept-source OCT Argos, swept-source OCT IOLMaster 700, swept-source OCT Anterion, PCI Pentacam AXL, OcuScan RxP and Itrace measurement
Eligibility Criteria
Patients with dense cataracts.
You may qualify if:
- LOCS III cataract classification with a grade of ≥3 for nuclear, cortical or posterior subcapsular.
- DLI index, from the ITrace device, should be ≤ 5.
You may not qualify if:
- Previous continuous contact lens wear
- Ocular trauma
- Intraocular lens surgery
- Poor fixation
- Corneal disease (i.e. keratoconus)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- OFTALVIST (Oftalmología Vistahermosa S.L)lead
- Alcon Researchcollaborator
Study Sites (1)
Oftalmología Vistahermosa SL
Alicante, Spain
Related Publications (1)
Tana-Rivero P, Aguilar-Corcoles S, Tana-Sanz P, Tana-Sanz S, Montes-Mico R. Axial length acquisition success rates and agreement of four optical biometers and one ultrasound biometer in eyes with dense cataracts. Eye Vis (Lond). 2023 Sep 1;10(1):35. doi: 10.1186/s40662-023-00352-3.
PMID: 37653460RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pedro Tañá, Dr.
Oftalmología Vistahermosa SL
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2022
First Posted
February 15, 2022
Study Start
February 10, 2022
Primary Completion
October 31, 2022
Study Completion
October 31, 2022
Last Updated
September 6, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share